Astellas to acquire Ocata Therapeutics for $379 million
10 November 2015 | By Victoria White
Acquiring Ocata will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy...
List view / Grid view
News
Baricitinib demonstrates superiority to adalimumab in rheumatoid arthritis
Baricitinib demonstrated superiority over adalimumab (Humira) after 12 weeks based on several critical measures of rheumatoid arthritis disease activity...
FDA approves Gilead’s Genvoya for the treatment of HIV
6 November 2015 | By Victoria White
Genvoya contains a new form of tenofovir that has not been previously approved...
Sanofi and Lexicon collaborate on sotagliflozin
6 November 2015 | By Victoria White
Sotagliflozin is an investigational new oral dual inhibitor of sodium-glucose cotransporters 1 and 2 which could be a potential treatment option for people with diabetes...
AstraZeneca to acquire ZS Pharma for $2.7 billion
6 November 2015 | By Victoria White
The transaction will give AstraZeneca access to the potassium-binding compound ZS-9, a potential best-in-class treatment for hyperkalaemia...
EMA validates type II variation application for Opdivo in RCC
6 November 2015 | By Victoria White
Validation of the application confirms the submission is complete and begins the EMA’s centralised review process...
INO-3112 shows robust responses in head and neck cancer
6 November 2015 | By Victoria White
Immunology results show that INO-3112 generated robust HPV16/18 specific CD8+ T cell responses and antibodies against HPV16/18...
UCART19 used to treat ‘incurable’ leukaemia
6 November 2015 | By Victoria White
A team at Great Ormond Street Hospital has used UCART 19 cells to treat a one-year-old girl who had relapsed acute lymphoblastic leukaemia with positive results...
Novo Nordisk presents findings of obesity care study
5 November 2015 | By Victoria White
Results from the study highlight a general lack of understanding of obesity as a disease and its impact on the body...
Johnson & Johnson to acquire Novira Therapeutics
5 November 2015 | By Victoria White
The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778...
Sanofi and Hanmi announce diabetes license agreement
5 November 2015 | By Victoria White
Sanofi and Hanmi have entered a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments...
Dry eye syndrome treatment market value to grow to $4.6b by 2024
5 November 2015 | By Victoria White
GlobalData says this rise will be driven primarily by the introduction of novel drugs, most notably Shire’s lifitegrast, a first-in-class drug with anti-inflammatory benefits...
Saxenda demonstrates significant and sustained weight loss over three years
4 November 2015 | By Victoria White
Saxenda in combination with reduced-calorie diet and increased physical activity also delayed the onset of type 2 diabetes in the three-year extension trial...
Janssen submits application to EMA to expand use of ibrutinib
4 November 2015 | By Victoria White
Janssen-Cilag International has submitted a Type II variation application to the European Medicines Agency (EMA), which seeks to broaden the existing marketing authorisation for Imbruvica (ibrutinib) to include previously untreated patients with chronic lymphocytic leukaemia (CLL).
NEB® launches new NEBNext® Ultra™ II Kit for NGS Library Preparation with as little as 500 pg of input DNA
4 November 2015 | By New England BioLabs, Inc.
New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems...
